Clinical trial
The Interplay Between Inborn Error of Immunity and Blood Disorders: Unravelling Immune Defects Behind Common Haematological Diseases
NCT06857604 is registered in ClinicalTrials.gov with Meyer Children's Hospital IRCCS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Interplay Between Inborn Error of Immunity and Blood Disorders: Unravelling Immune Defects Behind Common Haematological Diseases
- Lead sponsor
- Meyer Children's Hospital IRCCS
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 15, 2024
- Completion date
- July 31, 2027
- Enrollment
- 700 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.